Durham, NC, United States of America

Karen Elizabeth Lackey

This inventor holds 28 USPTO granted patents and 6 published patent applications, primarily in Protein Kinase Inhibitors. Top assignees: Smithkline Beecham Corporation, Glaxo Wellcome Inc., Glaxosmithkline LLC. Active years: 2000-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karen Elizabeth Lackey. Retrieved from https://idiyas.com/inventor/karen-elizabeth-lackey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 

% Patents Active = 28.6

Average Co-Inventor Count = 3.3

ph-index = 10

Forward Citations = 589(Granted Patents)


Location History:

  • Hillsborough, NC (US) (2001 - 2013)
  • Durham, NC (US) (2000 - 2015)

Company Filing History:


Years Active: 2000-2015

Loading Chart...
Areas of Expertise:
Heterocyclic Compounds
Protein Tyrosine Kinase
Cancer Treatment
Oxindole Derivatives
Anilinoquinazolines
Substituted Aza-Oxindole
Bicyclic Heteroaromatic
Receptor Tyrosine Kinase
28 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Karen Elizabeth Lackey

Introduction: Karen Elizabeth Lackey, based in Durham, NC, has made significant strides in the field of pharmaceuticals and biochemistry. With an impressive portfolio of 28 patents, her work has had a profound impact on medical research and drug development.

Latest Patents: Among her notable contributions, Lackey's latest patents include groundbreaking advancements in "Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors." These pharmaceutical formulations focus on innovative compounds designed to inhibit key proteins involved in various diseases, showcasing her dedication to advancing medical science.

Career Highlights: Karen Lackey has held prominent positions in leading pharmaceutical companies, including SmithKline Beecham Corporation and Glaxo Wellcome Inc. Her expertise in biochemistry and pharmacology has contributed to substantial progress within these reputable organizations, driving research initiatives and product development.

Collaborations: Throughout her career, Lackey has collaborated with esteemed colleagues such as George Stuart Cockerill and Lee Frederick Kuyper. These partnerships have not only enriched her research experience but have also fostered an environment of innovation, leading to successful advancements in drug discovery.

Conclusion: Karen Elizabeth Lackey exemplifies the spirit of innovation inherent in the field of pharmaceuticals. Her numerous patents and collaborative efforts highlight her commitment to improving healthcare through scientific research and development. As she continues to pave the way for new breakthroughs, her contributions will undoubtedly resonate within the industry for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…